# Sopherion Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sopherion-therapeutics

- Industry: Biotechnology
- Headquarters: Princeton, US
- Website: www.sopherion.com
- Total disclosed funding: $128M
- Latest round: Series C (Feb 18, 2009)
- Investors on record: 11

## About

Sopherion Therapeutics is a privately held biopharmaceutical company headquartered in Princeton, New Jersey. It develops and commercializes anti-cancer agents.

## Funding rounds

- Series C, Feb 18, 2009, $55M — Zoticon Bioventures
- Series B, Sep 23, 2004, $47M — Sprout Group, TL Ventures, HealthCap, Canaan Partners, Seaflower Ventures, NewSpring, ProQuest Investments
- Series A, Mar 10, 2003, $26M — Intersouth Partners, TL Ventures, HealthCap, Seaflower Ventures, Johnson & Johnson Innovation, Connecticut Innovations, ProQuest Investments

## Investors

- Intersouth Partners (https://capitalatlas.ai/funds/intersouth-partners) — Series A
- TL Ventures (https://capitalatlas.ai/funds/tl-ventures) — Series A, Series B
- HealthCap — Series A, Series B
- Seaflower Ventures (https://capitalatlas.ai/funds/seaflower-ventures) — Series A, Series B
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series A
- Connecticut Innovations (https://capitalatlas.ai/funds/connecticut-innovations) — Series A
- ProQuest Investments (https://capitalatlas.ai/funds/proquest-investments) — Series A, Series B
- Sprout Group (https://capitalatlas.ai/funds/sprout-group) — Series B
- Canaan Partners (https://capitalatlas.ai/funds/canaan-partners) — Series B
- NewSpring (https://capitalatlas.ai/funds/newspring) — Series B
- Zoticon Bioventures (https://capitalatlas.ai/funds/zoticon-bioventures) — Series C